Biocryst Pharmaceuticals Inc (BCRX)

Add to Watchlists
Create an Alert
3.455 -0.10  -2.95% NASDAQ Jul 17, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2019 11:00 EDT Misc Biocryst Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Biocryst Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
05/29/2019 10:00 EDT Misc Biocryst Pharmaceuticals Inc Annual General Meeting in 2018
05/08/2019 Earnings Biocryst Pharmaceuticals Inc First Quarter Earnings in 2019 Release
05/08/2019 08:30 EDT Misc Biocryst Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019
03/14/2019 Misc Biocryst Pharmaceuticals Inc Annual Report in 2018
03/04/2019 08:30 EST Misc Biocryst Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
03/04/2019 Earnings Biocryst Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release
11/06/2018 08:30 EST Misc Biocryst Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018
11/06/2018 Earnings Biocryst Pharmaceuticals Inc Third Quarter Earnings in 2018 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.biocryst.com
  • Investor Relations URL: http://investor.shareholder.com/biocryst/index.cfm
  • HQ State/Province: North Carolina
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 07, 2019
  • Last Earnings Release: May. 08, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Biocryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("BCRX","name")
  • Description: =YCI("BCRX","description")
  • Sector: =YCI("BCRX","sector")
  • Industry: =YCI("BCRX","industry")
  • Est. Current Fiscal Year End: =YCI("BCRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.